Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP718296.RAUcTRQV64OFPcWS1HB3gM1ZLI6c6CjKrPQWdpsqE2RrI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP718296.RAUcTRQV64OFPcWS1HB3gM1ZLI6c6CjKrPQWdpsqE2RrI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP718296.RAUcTRQV64OFPcWS1HB3gM1ZLI6c6CjKrPQWdpsqE2RrI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP718296.RAUcTRQV64OFPcWS1HB3gM1ZLI6c6CjKrPQWdpsqE2RrI130_provenance.
- befree-20150227 importedOn "2015-02-27" NP718296.RAUcTRQV64OFPcWS1HB3gM1ZLI6c6CjKrPQWdpsqE2RrI130_provenance.
- NP718296.RAUcTRQV64OFPcWS1HB3gM1ZLI6c6CjKrPQWdpsqE2RrI130_assertion wasGeneratedBy ECO_0000203 NP718296.RAUcTRQV64OFPcWS1HB3gM1ZLI6c6CjKrPQWdpsqE2RrI130_provenance.
- NP718296.RAUcTRQV64OFPcWS1HB3gM1ZLI6c6CjKrPQWdpsqE2RrI130_assertion wasDerivedFrom befree-20150227 NP718296.RAUcTRQV64OFPcWS1HB3gM1ZLI6c6CjKrPQWdpsqE2RrI130_provenance.
- NP718296.RAUcTRQV64OFPcWS1HB3gM1ZLI6c6CjKrPQWdpsqE2RrI130_assertion SIO_000772 12921752 NP718296.RAUcTRQV64OFPcWS1HB3gM1ZLI6c6CjKrPQWdpsqE2RrI130_provenance.
- NP718296.RAUcTRQV64OFPcWS1HB3gM1ZLI6c6CjKrPQWdpsqE2RrI130_assertion evidence source_evidence_literature NP718296.RAUcTRQV64OFPcWS1HB3gM1ZLI6c6CjKrPQWdpsqE2RrI130_provenance.
- NP718296.RAUcTRQV64OFPcWS1HB3gM1ZLI6c6CjKrPQWdpsqE2RrI130_assertion description "[Consistent with this idea, blockade of IL-4 by antibody treatment or of its signaling by inactivation of the Stat6 gene ameliorates glomerulosclerosis and delays or even prevents the development of end-stage renal disease, despite the presence of high levels of IgG anti-dsDNA Antibodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718296.RAUcTRQV64OFPcWS1HB3gM1ZLI6c6CjKrPQWdpsqE2RrI130_provenance.